Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hansen

Showing results (1391-1400 of 1,659) with videos related to

Pageof 166
Sort By:
Biomedical Engineering Online|November 1, 2019
Automatic sleep stage classification based on subcutaneous EEG in patients with epilepsySirin W Gangstad, Kaare B Mikkelsen, Preben Kidmose, et al.
Archiv Der Pharmazie|June 23, 2017
Isophthalic Acid-Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoniKatharina Stenzel, Alokta Chakrabarti, Jelena Melesina, et al.
European Journal of Medicinal Chemistry|May 7, 2024
Preferential HDAC6 inhibitors derived from HPOB exhibit synergistic antileukemia activity in combination with decitabineMaik Tretbar, Julian Schliehe-Diecks, Lukas von Bredow, et al.
Diabetologia|February 25, 2011
Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus--an adaptive response to hyperglycaemia?A M K Hansen, T B Bödvarsdottir, D N E Nordestgaard, et al.
Diabetes|April 16, 2009
Elevated MBL concentrations are not an indication of association between the MBL2 gene and type 1 diabetes or diabetic nephropathyMari A Kaunisto, Lisa Sjölind, Riitta Sallinen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 21, 2004
Studies of relationships between variation of the human G protein-coupled receptor 40 Gene and Type 2 diabetes and insulin releaseY H Hamid, H Vissing, B Holst, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget DrugsLukas von Bredow, Thomas Martin Schäfer, Julian Hogenkamp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2014
Mode of delivery shapes gut colonization pattern and modulates regulatory immunity in miceCamilla H F Hansen, Line S F Andersen, Lukasz Krych, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 24, 2026
Comparative cost per responder analysis of Ciltacabtagene autoleucel and real-world standard of Care therapy in patients with lenalidomide-refractory multiple myelomaDoris K Hansen, Xiaoxiao Lu, Omar Castaneda Puglianini, et al.
Analytical Biochemistry|September 27, 2016
Metabolic tracing of monoacylglycerol acyltransferase-2 activity in vitro and in vivoJenson Qi, Wensheng Lang, Margery A Connelly, et al.
Pageof 166

Showing results (1391-1400 of 1,659) with videos related to

Sort By:
Pageof 166
Biomedical Engineering Online|November 1, 2019
Automatic sleep stage classification based on subcutaneous EEG in patients with epilepsySirin W Gangstad, Kaare B Mikkelsen, Preben Kidmose, et al.
Archiv Der Pharmazie|June 23, 2017
Isophthalic Acid-Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoniKatharina Stenzel, Alokta Chakrabarti, Jelena Melesina, et al.
European Journal of Medicinal Chemistry|May 7, 2024
Preferential HDAC6 inhibitors derived from HPOB exhibit synergistic antileukemia activity in combination with decitabineMaik Tretbar, Julian Schliehe-Diecks, Lukas von Bredow, et al.
Diabetologia|February 25, 2011
Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus--an adaptive response to hyperglycaemia?A M K Hansen, T B Bödvarsdottir, D N E Nordestgaard, et al.
Diabetes|April 16, 2009
Elevated MBL concentrations are not an indication of association between the MBL2 gene and type 1 diabetes or diabetic nephropathyMari A Kaunisto, Lisa Sjölind, Riitta Sallinen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 21, 2004
Studies of relationships between variation of the human G protein-coupled receptor 40 Gene and Type 2 diabetes and insulin releaseY H Hamid, H Vissing, B Holst, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget DrugsLukas von Bredow, Thomas Martin Schäfer, Julian Hogenkamp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2014
Mode of delivery shapes gut colonization pattern and modulates regulatory immunity in miceCamilla H F Hansen, Line S F Andersen, Lukasz Krych, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 24, 2026
Comparative cost per responder analysis of Ciltacabtagene autoleucel and real-world standard of Care therapy in patients with lenalidomide-refractory multiple myelomaDoris K Hansen, Xiaoxiao Lu, Omar Castaneda Puglianini, et al.
Analytical Biochemistry|September 27, 2016
Metabolic tracing of monoacylglycerol acyltransferase-2 activity in vitro and in vivoJenson Qi, Wensheng Lang, Margery A Connelly, et al.
Pageof 166